a CHU UCL Namur, Namur Thrombosis and Hemostasis Center, Hematology Laboratory , Université Catholique de Louvain , Yvoir , Belgium.
b Section of Clinical Biochemistry , University Hospital of Verona , Verona , Italy.
Crit Rev Clin Lab Sci. 2018 Dec;55(8):548-577. doi: 10.1080/10408363.2018.1529734.
D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of activation of coagulation and fibrinolysis, and it is routinely used for ruling out venous thromboembolism (VTE). D-dimer is increasingly used to assess the risk of VTE recurrence and to help define the optimal duration of anticoagulation treatment in patients with VTE, for diagnosing disseminated intravascular coagulation, and for screening medical patients at increased risk of VTE. This review is aimed at (1) revising the definition of D-dimer; (2) discussing preanalytical variables affecting the measurement of D-dimer; (3) reviewing and comparing assay performance and some postanalytical variables (e.g. different units and age-adjusted cutoffs); and (4) discussing the use of D-dimer measurement across different clinical settings.
D-二聚体是一种可溶性纤维蛋白降解产物,来源于纤溶酶介导的交联纤维蛋白的降解。因此,D-二聚体可以被认为是凝血和纤溶激活的生物标志物,常用于排除静脉血栓栓塞症(VTE)。D-二聚体越来越多地用于评估 VTE 复发的风险,并帮助确定 VTE 患者抗凝治疗的最佳持续时间,用于诊断弥散性血管内凝血,并用于筛查 VTE 风险增加的住院患者。这篇综述的目的是:(1)修订 D-二聚体的定义;(2)讨论影响 D-二聚体测量的分析前变量;(3)回顾和比较检测性能和一些分析后变量(例如不同的单位和年龄校正的截断值);(4)讨论在不同临床环境中使用 D-二聚体测量的情况。